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ollicular thyroid carcinoma (FTC) is the second most common thyroid malig-
nancy and accounts for approximately 10% of all thyroid malignancies.1
Lymph node metastases are uncommon, and distant pulmonary or bony
metastases are more common in patients with FTC than papillary thyroid
carcinoma (PTC). Metastasis to the internal jugular vein (IJV) from a thyroid malig-
nancy is not common, and most are direct invasions from the outside wall of the IJV.
However, our case was a hematogenous intravascular metastasis that was easily diag-
nosed by sonographically guided fine-needle aspiration biopsy (FNAB).
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CT, computed tomography; FDG, fluorodeoxyglucose;
FNAB, fine-needle aspiration biopsy; FTC, follicular thy-
roid carcinoma; IJV, internal jugular vein; PET, positron
emission tomography; PTC, papillary thyroid carcinoma;
Tg, thyroglobulin
Case Report
A 52-year-old man was referred for sonographic exami-
nation to evaluate a hypermetabolic lesion that suggest-
ed metastasis in his left neck. He had undergone total
thyroidectomy and cervical lymph node sampling
because of 4-cm widely invasive FTC at an outside hospi-
tal. No cervical lymph node metastasis was observed. The
patient then received radioactive iodine ablation therapy
with 200 mCi. During the follow-up period, his serum
thyroglobulin (Tg) level was maintained within normal
ranges, but 4 years 9 months after the surgery, it was ele-
vated at 861 ng/mL. Outside [18F]fluorodeoxyglucose
(FDG)-positron emission tomography (PET)/computed
tomography (CT) showed a hot-uptake lesion in his left
pubic bone area, and he was referred to our hospital. At
that time, there was no other hypermetabolic lesion in his
neck area (Figure 1). He underwent partial resection for a
left pubic bone mass 1 month later, but the mass was not
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complete excised. Then he underwent radiation
therapy with 4500 cGy to his pubic area. His
serum Tg level was markedly decreased at 36.7
ng/mL but was still high. Subsequent [18F]FDG-
PET/CT was performed to evaluate a residual
lesion at the excision site 3 months after the
resection, and it showed a newly developed
hypermetabolic lesion in the left paratracheal
region (Figure 2).
A neck sonographic examination was per-
formed to evaluate the hypermetabolic lesion,
and it showed a round, mainly hyperechoic mass
within his left IJV (Figure 3A). His left IJV was par-
tially occluded by the mass, and there was no
other suspicious extravascular lesion at the level
of the mass. On a color Doppler image, there
was a color signal within the mass (Figure 3B).
Sonographically guided FNAB of the intravas-
cular mass was performed, and the aspirated
specimen showed numerous clusters of micro-
follicle-forming atypical cells, which suggested
metastatic FTC (Figure 4A). A wide excision of
the left IJV containing the intravascular mass was
performed, and the mass was finally confirmed
to be hematogenously metastatic FTC (Figure
4B). On follow-up neck sonography, there was no
evidence of recurrence at the operation site, and
his serum Tg level was 6.8 ng/mL 8 months later
because of the residual bony lesion.
Discussion
Follicular thyroid carcinoma is generally consid-
ered a more aggressive tumor than papillary thy-
roid cancer,1 and PTC and FTC carry 10-year
overall survival rates of 93% and 85%, respective-
ly.2 Lymph node metastases are uncommon in
patients with FTC, occurring in approximately
10%, whereas approximately 50% of patients
with PTC have at least microscopic lymph node
metastases. In addition, distant pulmonary or
bone metastases are more common in patients
with FTC (30%) compared to those with PTC
(15%).1 Clinical presentations of FTC are diverse
and range from skull masses to bulbar palsy.3
Follicular cancer occurs more often in women,
and the female to male ratio is 3:1. The mean age
at presentation is 50 years, and it is more com-
mon in areas of iodine deficiency.4
Histopathologically, the recent World Health
Organization classification of tumors divided fol-
licular carcinomas into 2 major categories,
according to their degree of invasiveness, as fol-
lows: minimally and widely invasive follicular
carcinoma.5 Minimally invasive follicular car-
cinomas have limited capsular and vascular
invasion, whereas widely invasive follicular carci-
nomas have widespread infiltration of adjacent
thyroid tissues and blood vessels.5 Van Heerden
et al6 reported that only distant metastasis at
diagnosis had independent prognostic signifi-
cance (P < .0001) in the prediction of cause-
 specific mortality. According to their report, there
had been no cancer-related mortality and no
distant metastasis in 20 patients who had surgi-
cally treated minimally invasive FTC during a
mean 10-year follow-up period, and the vascular
660 J Ultrasound Med 2010; 29:659–662
Intravascular Metastasis From Follicular Thyroid Carcinoma
Figure 1. Outside axial [18F]FDG-PET/CT shows no hypermetabolic lesion in the
left carotid space.
Figure 2. Follow-up axial [18F]FDG-PET/CT performed 4 months after Figure 1
shows a hypermetabolic lesion, which suggests metastasis in the patient’s left neck
region.
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invasion increased the disease-specific mortality
at 10 years to 28%.6 The probability of aggressive
behavior increases with the extent of vascular
invasion because of the greater probability of
recurrence and metastases caused by angioinva-
sion; therefore, the risk of metastatic disease in
patients with widespread vascular invasion is
substantial.5,7 The tumor type of our patient was
a widely invasive follicular carcinoma, which
suggested that he was at risk of metastasis.
Additionally, Lo et al7 had reported that older
patients (men ≥40 and women ≥50 years) had a
greater risk (10.4 times) than younger patients.
The International Union Against Cancer/
American Joint Committee on Cancer pTNM
staging system also considers the age at presen-
tation (45 years, any sex) and adopted size crite-
ria as relevant to cancer-specific survival.8 Our
patient was a man, and his age at presentation
was 47 years, which presented an additional risk
factor.
Distant metastasis in differentiated thyroid
cancer can be divided into 2 categories: distant
metastasis as the initial diagnosis and distant
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Figure 3. A, Neck sonography reveals a round, mainly hyperechoic mass suggesting metastasis from thyroid cancer within the patient’s left IJV. B, Color
Doppler imaging shows a color signal at the center and periphery of the mass.
A B
Figure 4. A, Cytologic specimen shows many clusters of microfollicle-forming atypical cells, suggestive of a follicular neoplasm (hematoxylin-eosin, original
magnification ×400). B, Histologically, the tumor cells proliferate, forming well-developed follicles or solid nests. They invade to the venous walls aggressively
(arrow), which is shown by the positivity of smooth muscle actin immunostaining (inset, arrowhead; original magnifications ×40 and ×100, respectively).
A B
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metastasis after initial treatment of thyroid can-
cer. The most frequent site of metastatic disease
is either the lungs or bones,2,9 and there have
been few reports regarding skeletal or skin
metastases diagnosed by FNAB.10,11 According to
these reports, FNAB is a useful diagnostic tool
for metastatic FTC, but it is difficult to diagnose
follicular neoplasms by FNAB.3,10–12
This case was unique because it was a hemato -
genously metastasizing intravascular mass from
FTC and not from a direct invasion, and it was a
delayed metastasis. There was a report of thyroid
insular carcinoma with jugular vein invasion, but
it was different from our case because of its
timing and cell type.13 The reported case was
an initial metastatic lesion, and it was a locally
aggressive mass, but this case involved delayed
metastasis. On sonography, this metastatic lesion
showed echogenicity and characteristics similar
to those of benign-looking thyroid nodules,
which provided a clue for diagnosis.
In summary, FTC can metastasize into the vas-
cular lumen and not by direct invasion. An initial
large tumor size, a widely invasive type, and age
older than 40 years in men, could be risk factors
for metastasis. 
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